The Risperdal lawsuit is ongoing, and complicated.
In this article we will discuss the different charges Janssen Pharmaceuticals, the maker of Risperdal, is facing regarding illegal marketing practices with their drug Risperdal.
Janssen is putting profits over safety, putting lives at risk.
Janssen Pharmaceuticals is a subsidiary of Johnson and Johnson.
Risperdal has a long, dark history of bribery, illegal marketing, and dangerous side effects.
Risperdal is a brand name, atypical antipsychotic medication. It’s active ingredient is called risperdone.
Janssen now faces many Risperdal lawsuits, and has already plead guilty to advertising the drug for “off-label” uses.
Off-label marketing is when a company advertises for a drug to be used for purposes that are not FDA approved; they are “off the label” uses.
What are the FDA Approved Uses of Risperdal?
Originally, Risperdal was released in 1993.
At first Risperdal was only FDA approved for treating psychosis in adults with schizophrenia. Risperdal was later FDA approved for children aged 5-17 to help with the irritability associated with autism spectrum disorders.
On August 22nd, 2007, Risperdal received FDA approval to be used for treating schizophrenia in adolescents aged 13-17, and short term treatment of mania, a symptom of bipolar disorder in kids age 10 and up.
Risperdal became the first atypical antipsychotic drug to be approved to treat schizophrenia and bipolar disorder in children.
However, doctors are urged to keep in mind that Risperdal has serious side effects such as weight gain, and can cause gynecomastia in adolescent boys.
Johnson and Johnson has been sued for marketing Risperdal illegally for use with children with ADHD, persons with intellectual disability, and older adults with dementia.
Prosecutors accuse Johnson and Johnson of targeting our most vulnerable populations with what is essentially a chemical restraint.
Janssen Pharmaceuticals is also accused of down playing the risks of Risperdal, while marketing the drug for unapproved uses. This is not the first time Janssen Pharmaceuticals has gotten into trouble over Risperdal.
Janssen Has a History of Illegally Marketing Risperdal
The current Risperdal scandal is certainly not the first: Janssen has been sued by numerous state governments for their unethical and illegal marketing of Risperdal.
Risperdal was sold illegally as a “chemical restraint” in nursing homes, putting lives at risk.
Risperdal is not approved for use with dementia in the elderly, but it has been used for such in the past.
Risperdal becomes what is known as a “chemical restraint” in a nursing home setting, ensuring that elderly residents will sleep through the night. Charges brought forth against Janssen allege that the company pitched sales to nursing homes saying they would save money by need less staff thanks to the sedative effect of Risperdal.
Former employees of Janssen Pharmaceuticals began to step forward.
They were called whistle blowers. They came forward and testified against Janssen in state court.
Former Janssen Employees Testify in Risperdal Lawsuit
Whistle blower Judy Doetterl testified that she was pressured to sell Risperdal to elder care facilities, saying that 70% of her bonus depended on it.
Doetterl knew that Risperdal was not FDA approved for use with dementia, and complained to management. Her complaints were ignored.
Doetterl wasn’t the only whistle bower to come forward; 7 others testified against Janssen for their illegal marketing of Risperdal.
Kurtis Barry, another whistle blower in the Risperdal lawsuit, was a former regional sales manager for Janssen Pharmaceuticals. He testified that the CEO of Johnson and Johnson, Alex Gorsky, knowingly and willingly directed that Risperdal be marketed to the elderly for use with dementia.
“The decision to market, promote and sell Risperdal for off-label purposes to the elderly population was made affirmatively and deliberately by defendants’ executive and management personnel, and carried out under their authority and direction.” – Kurtis Barry
The problem is, Risperdal can be deadly for the elderly. The FDA has issued a blackbox warning on Risperdal packaging warning about the risks of taking Risperdal as an older adult.
The FDA Black Box Warning on Risperdal Labels.
When given to older adults with dementia, Risperdal increases the likelihood of death from conditions such as pneumonia and stroke.
Risperdal is not, nor has it ever been approved for use with older adults with dementia.
Janssen Pays Risperdal Settlements
Janssen has lost over and over again in state courts across the nation, yet is careful not to own up to their actions, saying they agree with the principles the prosecutors are standing by, but do not feel as though they violated the law.
Janssen officials say they agree with the sentiment that medicine should only be used for FDA approved purposes, but they deny having participated in any wrong-doing regarding the marketing of Risperdal to children.
Janssen was also found to have been giving illegal and unethical incentives to doctors and hospitals to prescribe Risperdal.
Even though they deny wrong-doing in public statements, Janssen continues to plead guilty in the court room, paying billions in settlements.
The Risperdal scandal has resulted in the 3rd largest medical settlement in history.
Johnson and Johnson has been fined over $2.2 billion dollars for the inappropriate and illegal marketing of Risperdal.
The Risperdal lawsuit alleged that Janssen Pharmaceuticals illegally marketed Risperdal the the elderly and children with certain behavioral disorders.
Given that Risperdal isn’t approved for these uses, the prosecutor claimed Janssen Pharmaceuticals put some of our most vulnerable populations – children and the elderly – at risk, because Risperdal has serious side effects and can be deadly to the elderly.
Despite the large Risperdal settlement amounts being awarded on state and federal levels, Johnson and Johnson continues to profit on sales of Risperdal.
The Risperdal Gynecomastia Lawsuit
Can Janssen continue to rake in enough sales to break the law?
Janssen has been court-ordered to pay billions in Risperdal settlements, but Risperdal is still a profitable drug for Johnson and Johnson.
This is why many feel as though a lawsuit is the only way they can fight back after being manipulated and injured by a corporation like Johnson and Johnson.
We help the “little guy” fight back.
If you have been affected by Risperdal gynecomastia you have experienced pain and suffering, weight gain, hormonal imbalance, and you may have needed corrective surgery for the gynecomastia.
If you have experienced these Risperdal side effects we strongly urge you to seek legal advice, as recovering from Risperdal gynecomastia can be an expensive and painful journey.
Attorneys Band Gates & Dramis offers free, no obligation Risperdal claims evaluations.
Plaintiffs in the current Risperdal lawsuit feel as though Janssen is liable for any damages, due to the aggressive nature in which Risperdal was marketed and the fact that Janssen chose not to warn users about the possible side effect of hormonal imbalance and gynecomastia.
To begin researching your claim with Risperdal lawyers today, fill out the online form on this page or simply call the number below.
We do not charge a fee unless you collect a settlement.
Risperdal Lawsuit Help